These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparison of the Effectiveness and Safety of Linezolid and Daptomycin in Vancomycin-Resistant Enterococcal Bloodstream Infection: A National Cohort Study of Veterans Affairs Patients. Britt NS; Potter EM; Patel N; Steed ME Clin Infect Dis; 2015 Sep; 61(6):871-8. PubMed ID: 26063715 [TBL] [Abstract][Full Text] [Related]
4. Vancomycin-resistant enterococci infection and predisposing factors for infection and mortality in patients with acute leukaemia and febrile neutropenia. Kirkizlar TA; Akalin H; Kirkizlar O; Ozkalemkas F; Ozkocaman V; Kazak E; Ozakin C; Bulbul EN; Ozboz ES; Ali R Leuk Res; 2020 Dec; 99():106463. PubMed ID: 33130331 [TBL] [Abstract][Full Text] [Related]
5. Daptomycin versus linezolid for the treatment of vancomycin-resistant enterococcal bacteraemia: implications of daptomycin dose. Chuang YC; Lin HY; Chen PY; Lin CY; Wang JT; Chang SC Clin Microbiol Infect; 2016 Oct; 22(10):890.e1-890.e7. PubMed ID: 27475738 [TBL] [Abstract][Full Text] [Related]
6. Editorial Commentary: Linezolid vs Daptomycin for Vancomycin-Resistant Enterococci: The Evidence Gap Between Trials and Clinical Experience. McKinnell JA; Arias CA Clin Infect Dis; 2015 Sep; 61(6):879-82. PubMed ID: 26063714 [No Abstract] [Full Text] [Related]
7. A therapeutic benefit of daptomycin against glycopeptide-resistant gram-positive cocci bloodstream infections under neutropenia. Matsuda K; Koya J; Toyama K; Ikeda M; Arai S; Nakamura F; Okugawa S; Moriya K; Kurokawa M J Infect Chemother; 2017 Nov; 23(11):788-790. PubMed ID: 28743428 [TBL] [Abstract][Full Text] [Related]
8. Impact of different antimicrobial therapies on clinical and fiscal outcomes of patients with bacteremia due to vancomycin-resistant enterococci. Hayakawa K; Martin ET; Gudur UM; Marchaim D; Dalle D; Alshabani K; Muppavarapu KS; Jaydev F; Bathina P; Sundaragiri PR; Rajuri SD; Khatri J; Pogue JM; Lephart PR; Rybak MJ; Kaye KS Antimicrob Agents Chemother; 2014 Jul; 58(7):3968-75. PubMed ID: 24798267 [TBL] [Abstract][Full Text] [Related]
9. E. faecalis vancomycin-sensitive enterococcal bacteremia unresponsive to a vancomycin tolerant strain successfully treated with high-dose daptomycin. Cunha BA; Mickail N; Eisenstein L Heart Lung; 2007; 36(6):456-61. PubMed ID: 18005808 [TBL] [Abstract][Full Text] [Related]
10. Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study. Crank CW; Scheetz MH; Brielmaier B; Rose WE; Patel GP; Ritchie DJ; Segreti J Clin Ther; 2010 Sep; 32(10):1713-9. PubMed ID: 21194593 [TBL] [Abstract][Full Text] [Related]
11. Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis. Chuang YC; Wang JT; Lin HY; Chang SC BMC Infect Dis; 2014 Dec; 14():687. PubMed ID: 25495779 [TBL] [Abstract][Full Text] [Related]
12. Effect of Continuous and Sequential Therapy among Veterans Receiving Daptomycin or Linezolid for Vancomycin-Resistant Enterococcus faecium Bacteremia. Britt NS; Potter EM; Patel N; Steed ME Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264856 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic options for vancomycin-resistant enterococcal bacteremia. Barber KE; King ST; Stover KR; Pogue JM Expert Rev Anti Infect Ther; 2015 Mar; 13(3):363-77. PubMed ID: 25661903 [TBL] [Abstract][Full Text] [Related]
15. A retrospective clinical comparison of daptomycin vs daptomycin and a beta-lactam antibiotic for treating vancomycin-resistant Enterococcus faecium bloodstream infections. Chuang YC; Chen PY; Lin CY; Chen YC; Wang JT; Chang SC Sci Rep; 2018 Jan; 8(1):1632. PubMed ID: 29374204 [TBL] [Abstract][Full Text] [Related]
16. Enterococcal bacteremia in febrile neutropenic children and adolescents with underlying malignancies, and clinical impact of vancomycin resistance. Bae KS; Shin JA; Kim SK; Han SB; Lee JW; Lee DG; Chung NG; Cho B; Jeong DC; Kang JH Infection; 2019 Jun; 47(3):417-424. PubMed ID: 30565009 [TBL] [Abstract][Full Text] [Related]
17. Optimizing therapy for vancomycin-resistant enterococcal bacteremia in children. Tamma PD; Hsu AJ Curr Opin Infect Dis; 2014 Dec; 27(6):517-27. PubMed ID: 25313503 [TBL] [Abstract][Full Text] [Related]
18. Treatment considerations in vancomycin-resistant enterococcal bacteremia: daptomycin or linezolid? A review. Shukla BS; Gauthier TP; Correa R; Smith L; Abbo L Int J Clin Pharm; 2013 Oct; 35(5):697-703. PubMed ID: 23893061 [TBL] [Abstract][Full Text] [Related]
19. Daptomycin for the treatment of bacteraemia due to vancomycin-resistant enterococci. Munita JM; Murray BE; Arias CA Int J Antimicrob Agents; 2014 Nov; 44(5):387-95. PubMed ID: 25261158 [TBL] [Abstract][Full Text] [Related]
20. Effect of Daptomycin Dose on the Outcome of Vancomycin-Resistant, Daptomycin-Susceptible Enterococcus faecium Bacteremia. Chuang YC; Lin HY; Chen PY; Lin CY; Wang JT; Chen YC; Chang SC Clin Infect Dis; 2017 Apr; 64(8):1026-1034. PubMed ID: 28329222 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]